SHARE CAPITAL (Tables)

12 Months Ended

Dec. 31, 2019

Stockholders' Equity Note [Abstract]

Schedule of Stock Option Activity

	Year ended December 31
	2019					2018
	Number of options			Weighted average exercise price		Number of options			Weighted average exercise price
				$					$
Outstanding at Beginning of year		854,656			2.53		331,660			4.03
Granted		-			-		568,500			2.00
Exercised		(47,644	)		0.1		-			-
Canceled and forfeited		(242,815	)		1.93		(45,504	)		6.84
Outstanding at end of year		564,197			2.64		854.656			2.53
Exercisable at end of year		315,822			3.32		291,156			3.44

Schedule of Stock-Based Compensation and Warrants Charge

	Year ended December 31,
	2019		2018
	$		$
Cost of revenues		66		116
Research and development expenses		31		54
Selling and marketing expenses		29		52
General and administrative expenses		18		35
		144		257

Schedule of Options Outstanding and Exercisable

Options outstanding							Options Exercisable
Range of exercise price	Number outstanding as of December 31, 2019		Weighted average remaining contractual life (years)		Weighted average exercise price		Aggregate intrinsic value		Number outstanding as of December 31, 2019		Weighted average remaining contractual life (years)		Weighted average exercise price		Aggregate intrinsic value
$					$		$						$		$
0.00-2.00		408,549		7.34		1.46		84,940		160,174		7.34		0.54		84,940
3.00-5.00		121,648		4.34		4.15		-		121,648		4.34		4.15		-
7.00-10.00		34,000		3.75		8.75		-		34,000		3.75		8.75		-
		564,197		6.41		2.16		84,940		315,822		5.71		2.82		84,940

Schedule of Non-vested Option Activity

	Options			Weighted– average grant-date fair value
Non-vested as of December 31, 2018		563,500			1.90
Granted		-			-
Vested		(72,310	)		2.00
Forfeited and canceled		(242,815	)		1.86
Non-vested as of December 31, 2019		248,375			1.92